Package 63020-049-01

{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "3ec85e73-696a-4a2e-aa24-656c6341b23b", "openfda": {"nui": ["N0000175604", "N0000175075"], "unii": ["69G8BD63PP"], "rxcui": ["402243", "402244"], "spl_set_id": ["1521d321-e724-4ffc-adad-34bf4f44fac7"], "pharm_class_epc": ["Proteasome Inhibitor [EPC]"], "pharm_class_moa": ["Proteasome Inhibitors [MoA]"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (63020-049-01)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL", "package_ndc": "63020-049-01", "marketing_start_date": "20030513"}], "brand_name": "VELCADE", "product_id": "63020-049_3ec85e73-696a-4a2e-aa24-656c6341b23b", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Proteasome Inhibitor [EPC]", "Proteasome Inhibitors [MoA]"], "product_ndc": "63020-049", "generic_name": "bortezomib", "labeler_name": "Takeda Pharmaceuticals America, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VELCADE", "active_ingredients": [{"name": "BORTEZOMIB", "strength": "3.5 mg/1"}], "application_number": "NDA021602", "marketing_category": "NDA", "marketing_start_date": "20030513", "listing_expiration_date": "20261231"}